Gyre Therapeutics, Inc. Common Stock Share Price
NASDAQ: GYREHealthcare
Live Gyre Therapeutics, Inc. Common Stock Share Price Chart
O H L
Gyre Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$6.89Low
$7.19High
Markets Today
| Previous Close | $7.18 |
|---|---|
| Open | $6.89 |
| Volume | 143,912 |
| Day's Range | $6.89 - $7.19 |
| 52W Range | $5.44 - $9.42 |
| Market Cap | $710.43 M |
Historical Performance
| 1M Returns | +2.87 |
|---|---|
| 3M Returns | +14.88 |
| 6M Returns | +2.43 |
| 1Y Returns | -6.63 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Gyre Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $710.43 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $116.59 M |
| ROE TTM | 0.06 |
| EPS TTM | $-0.20 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.58 |
| EBITDA | $14.01 M |
| Profit Margin | 4.31 |
| Market Cap | $710.43 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $116.59 M |
| ROE TTM | 0.06 |
| EPS TTM | $-0.20 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.58 |
| EBITDA | $14.01 M |
| Profit Margin | 4.31 |
Gyre Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $22.06 M | $29.73 M | $30.56 M | $37.20 M | $22.52 M | $29.11 M |
| Gross Profit + | $21.16 M | $28.58 M | $28.94 M | $35.45 M | $21.29 M | $26.90 M |
| Operating Income | $2.27 M | -$2.24 M | $6.93 M | $120.00 K | -$9.36 M | -$14.36 M |
| EBITDA | $2.81 M | -$1.23 M | $7.58 M | $815.00 K | -$8.68 M | -$12.88 M |
| Interest Expense | $0 | $0 | $0 | $1.75 M | $0 | $0 |
| Depreciation | $535.00 K | $1.01 M | $649.00 K | $695.00 K | $672.00 K | $1.48 M |
| Income Before Tax | $4.63 M | -$1.57 M | $7.63 M | -$66.00 K | -$9.24 M | -$14.43 M |
| Income Tax Expense | $901.00 K | $662.00 K | $1.69 M | $1.30 M | $621.00 K | -$164.00 K |
| Net Income + | $3.73 M | -$2.24 M | $5.94 M | -$1.37 M | -$9.86 M | -$14.27 M |
| Net Profit Margin | 16.93% | -7.52% | 19.42% | -3.67% | -43.78% | -49.03% |
Gyre Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $87.00 K | $91.00 K | $91.00 K | $91.00 K | $91.00 K | $106.00 K |
| Reserve & Surplus | -$73.24 M | -$72.60 M | -$68.40 M | -$113.51 M | -$77.08 M | -$136.47 M |
| Non-Current Liabilities | $6.50 M | $6.28 M | $6.06 M | $7.62 M | $5.24 M | $5.67 M |
| Current Liabilities | $18.99 M | $16.92 M | $15.91 M | $23.78 M | $19.79 M | $28.66 M |
| Total Liabilities | $25.49 M | $23.20 M | $21.97 M | $31.40 M | $25.03 M | $34.34 M |
| Fixed Assets | $28.60 M | $28.36 M | $28.45 M | $32.28 M | $28.20 M | $31.81 M |
| Current Assets | $68.45 M | $91.28 M | $98.58 M | $149.36 M | $91.73 M | $122.07 M |
| Total Assets | $129.79 M | $152.65 M | $159.38 M | $219.76 M | $162.01 M | $199.25 M |
Gyre Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $3.73 M | -$1.03 M | $5.94 M | -$1.37 M | -$9.86 M | -$22.99 M |
| Operating Cash Flow | -$129.00 K | -$7.47 M | $4.68 M | -$5.63 M | $3.18 M | -$16.73 M |
| Investing Cash Flow | $1.97 M | $1.35 M | -$1.25 M | $1.85 M | -$3.06 M | $9.76 M |
| Financing Cash Flow | $1.34 M | $20.25 M | $365.00 K | $318.00 K | $21.00 K | -$8.00 K |
| Change in Cash | $3.23 M | $14.09 M | $3.91 M | -$3.33 M | $431.00 K | -$6.34 M |
Gyre Therapeutics, Inc. Common Stock Return Calculator
The Gyre Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Gyre Therapeutics, Inc. Common Stock
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Popular Stocks
FAQs
What is the share price of Gyre Therapeutics, Inc. Common Stock today?
Gyre Therapeutics, Inc. Common Stock (GYRE) share price as of September 18, 2026 is $7.10. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Gyre Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Gyre Therapeutics, Inc. Common Stock (GYRE) Share by opening an international trading account with Angel One.
How can I purchase Gyre Therapeutics, Inc. Common Stock shares in India?
Purchasing Gyre Therapeutics, Inc. Common Stock (GYRE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Gyre Therapeutics, Inc. Common Stock (GYRE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Gyre Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Gyre Therapeutics, Inc. Common Stock (GYRE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Gyre Therapeutics, Inc. Common Stock?
The market capitalization of Gyre Therapeutics, Inc. Common Stock on September 18, 2026, is $710.43 M.
In which sector Gyre Therapeutics, Inc. Common Stock belongs?
Gyre Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Gyre Therapeutics, Inc. Common Stock stocks?
In order to invest in Gyre Therapeutics, Inc. Common Stock (GYRE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
